NasdaqGM - Nasdaq Real Time Price USD
Iovance Biotherapeutics, Inc. (IOVA)
At close: October 22 at 4:00 PM EDT
Pre-Market: 8:18 AM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Cash Flow
-388,761.00
-361,820.00
-292,757.00
-227,941.00
-205,134.00
--
Investing Cash Flow
-223,146.00
-155,242.00
256,455.00
132.00
-317,853.00
--
Financing Cash Flow
550,163.00
462,959.00
190,150.00
239,268.00
576,422.00
--
End Cash Position
234,696.00
181,318.00
238,161.00
84,313.00
72,854.00
--
Capital Expenditure
-11,719.00
-22,290.00
-20,425.00
-37,574.00
-46,791.00
--
Issuance of Capital Stock
552,966.00
463,281.00
189,502.00
203,156.00
567,043.00
--
Issuance of Debt
--
--
--
1,000.00
--
--
Free Cash Flow
-400,480.00
-384,110.00
-313,182.00
-265,515.00
-251,925.00
--
12/31/2019 - 10/15/2010
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TGTX TG Therapeutics, Inc.
24.25
-0.49%
FOLD Amicus Therapeutics, Inc.
11.87
-1.17%
HUMA Humacyte, Inc.
5.48
+2.62%
SMMT Summit Therapeutics Inc.
20.59
+0.44%
VKTX Viking Therapeutics, Inc.
62.03
-3.59%
IBRX ImmunityBio, Inc.
3.4900
-1.69%
ALT Altimmune, Inc.
6.80
-1.45%
WVE Wave Life Sciences Ltd.
14.83
-1.85%
TPST Tempest Therapeutics, Inc.
1.0500
0.00%
BIVI BioVie Inc.
3.3600
+27.76%